OxThera Company

OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
Technology: Others
Industry: PharmTech
Headquarters: Stockholm, Stockholms Lan, Sweden
Founded Date: 2005
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 10
Total Funding: €4.9M
Estimated Revenue: $10M to $50M
Last Funding Type: Seed

Visit Website
Register and Claim Ownership